Metabolic Syndrome: An Emerging Threat
Open accessAbstract
Metabolic syndrome (MetS) is a multifaceted syndrome, which occurs frequently in the general population. It represents a cluster of metabolic abnormalities that include hypertension, central obesity, insulin resistance, and atherogenic dyslipidemia, and is strongly associated with an increased risk for developing diabetes and atherosclerotic and nonatherosclerotic cardiovascular disease (CVD). The pathogenesis of MetS involves both genetic and acquired factors that contribute to the final pathway of inflammation that leads to CVD. MetS has gained significant importance recently due to the exponential increase in obesity worldwide. Early diagnosis is important in order to employ lifestyle and risk factor modification. Here, we review the epidemiology, diagnostic criteria, pathogenesis and disease associations of MetS, and summarize existing management modalities. Journal of Armed Forces Medical College Bangladesh Vol.14 (2) 2018: 203-208
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Age is related to metabolic changes.
“Gender affects hormonal and metabolic functions, age is related to metabolic changes, height is associated with body proportions and health, and waist circumference (WC) indicates central obesity, a key part of MetS [12, 13].”
From Machine learning with the body roundness index and associated indicators: a new approach to predicting metabolic syndrome (2025) · cites this paper as [12]
The Diagnostic Criteria section (p. 1) lists advancing age among factors considered in assessing metabolic syndrome, supporting an association between age and metabolic health. It does not describe metabolic changes that occur with age, so the claim is broader than the passage supports. (LLM, conf=0.76)
Experimental — accuracy not yet measuredWaist circumference indicates central obesity, a key part of metabolic syndrome.
“Gender affects hormonal and metabolic functions, age is related to metabolic changes, height is associated with body proportions and health, and waist circumference (WC) indicates central obesity, a key part of MetS [12, 13].”
From Machine learning with the body roundness index and associated indicators: a new approach to predicting metabolic syndrome (2025) · cites this paper as [12]
Height is associated with body proportions and health.
“Gender affects hormonal and metabolic functions, age is related to metabolic changes, height is associated with body proportions and health, and waist circumference (WC) indicates central obesity, a key part of MetS [12, 13].”
From Machine learning with the body roundness index and associated indicators: a new approach to predicting metabolic syndrome (2025) · cites this paper as [12]
The Introduction (p. 1) discusses body mass index and waist-to-hip ratio, and Systemic Effects (p. 3) discusses fat distribution around the waist. Neither addresses an association between height, body proportions, and health. Searches for height, stature, and related body-proportion terms found no passage supporting that claim. (LLM, conf=0.73)
Experimental — accuracy not yet measuredGender affects hormonal and metabolic functions.
“Gender affects hormonal and metabolic functions, age is related to metabolic changes, height is associated with body proportions and health, and waist circumference (WC) indicates central obesity, a key part of MetS [12, 13].”
From Machine learning with the body roundness index and associated indicators: a new approach to predicting metabolic syndrome (2025) · cites this paper as [12]
The Introduction (p. 1) reports differences in metabolic-syndrome prevalence by sex, while Systemic Effects (p. 3) lists reproductive conditions associated with the syndrome. Neither passage says that gender affects hormonal and metabolic functions; searches for sex-related hormonal and metabolic differences found no passage making that claim. (LLM, conf=0.72)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
1 retracted
A comprehensive review on metabolic syndrome
Kaur, J. (2014) · Cardiology Research and Practice · doi:10.1155/2014/943162 · Cited by 1,889 · see citing works
RetractedExpert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011 · see citing works
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · see citing works
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352 · see citing works
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902 · see citing works
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08905-5 · Cited by 2,543 · see citing works
Cinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A. S., & Obin, M. S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500294-jlr200 · Cited by 2,529 · see citing works
Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus
Wilson, P. W. F., D’Agostino, R. B., Parise, H., SULLIVAN, L. M., & Meigs, J. B. (2005) · Circulation · doi:10.1161/circulationaha.105.539528 · Cited by 2,061 · see citing works
Grundy, S. M., Cleeman, J. I., Bairey Merz, C. N., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.001 · Cited by 1,550 · see citing works
Metabolic syndrome: pathophysiology, management, and modulation by natural compounds
Rochlani, Y. M., Pothineni, N. V. K., Kovelamudi, S., & Mehta, J. L. (2017) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944717711379 · Cited by 1,103 · see citing works
American College of Endocrinology Position Statement on the Insulin Resistance Syndrome
Einhorn, D. (2003) · Endocrine Practice · doi:10.4158/ep.9.s2.5 · Cited by 1,066 · see citing works
The metabolic syndrome: prevalence in worldwide populations
Cameron, A. J., Shaw, J. E., & Zimmet, P. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.005 · Cited by 1,000 · see citing works
Howard, W. J. (2006) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70316-0 · Cited by 905 · see citing works
Etiology of Insulin Resistance
Petersen, K. F., & Shulman, G. I. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.009 · Cited by 825 · see citing works
Smith, S. C., Jr. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/g1ga-9884 · Cited by 748 · see citing works
Clustering of metabolic factors and coronary heart disease
Wilson, P. W. F., Kannel, W. B., Silbershatz, H., & D'Agostino, R. B. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.10.1104 · Cited by 712 · see citing works
Prevention of Type 2 Diabetes With Troglitazone in the Diabetes Prevention Program
The Diabetes Prevention Program Research Group* (2005) · Diabetes · doi:10.2337/diabetes.54.4.1150 · Cited by 474 · see citing works
Matsuzawa, Y., Funahashi, T., & Nakamura, T. (2011) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.7922 · Cited by 452 · see citing works
Screening Women With Polycystic Ovary Syndrome for Metabolic Syndrome
Dokras, A., Bochner, M., Hollinrake, E., Markham, S. M., Voorhis, B. J. V., & Jagasia, D. H. (2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000167408.30893.6b · Cited by 353 · see citing works
Olijhoek, J. K. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.12.007 · Cited by 295 · see citing works
The Prevalence of Metabolic Syndrome in Various Populations
Kolovou, G. D., Anagnostopoulou, K. K., Salpea, K. D., & Mikhailidis, D. P. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e318065c3a1 · Cited by 248 · see citing works
Metabolic Syndrome and Associated Diseases: From the Bench to the Clinic
Mendrick, D. L., Diehl, A. M., Topor, L. S., Dietert, R. R., Will, Y., Merrill, M. A. L., Bouret, S. G., Varma, V., Hastings, K. L., Schug, T. T., et al. (2017) · Toxicological Sciences · doi:10.1093/toxsci/kfx233 · Cited by 248 · see citing works
Schieffer, B., Bünte, C., Witte, J., Hoeper, K., Böger, R. H., Schwedhelm, E., & Drexler, H. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.03.065 · Cited by 239 · see citing works
Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach
Bellentani, S., Grave, R. D., Suppini, A., & Marchesini, G. (2007) · Hepatology · doi:10.1002/hep.22009 · Cited by 236 · see citing works
The evolving definitions and increasing prevalence of the metabolic syndrome.
Desroches, S., & Lamarche, B. (2007) · Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme · doi:10.1139/h06-095 · Cited by 183 · see citing works
Metabolic syndrome: time for action.
Deen, D. (2004) · PubMed · Cited by 165 · see citing works
The metabolic syndrome: common origins of a multifactorial disorder
Bruce, K. D., & Byrne, C. D. (2009) · Postgraduate Medical Journal · doi:10.1136/pgmj.2008.078014 · Cited by 164 · see citing works
Saleem, U., Khaleghi, M., Morgenthaler, N. G., Bergmann, A., Struck, J., Mosley, T. H., & Kullo, I. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2278 · Cited by 161 · see citing works
Essential hypertension, metabolic disorders, and insulin resistance
Ferrannini, E., & Natali, A. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90433-i · Cited by 147 · see citing works
(1998) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(98)00276-4 · Cited by 140 · see citing works
Tsimikas, S., Willeit, J., Knoflach, M., Mayr, M., Egger, G., Notdurfter, M., Witztum, J. L., Wiedermann, C. J., Xu, Q., & Kiechl, S. J. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn502 · Cited by 123 · see citing works
Jacobs, M., van Greevenbroek, M. M. J., Kallen, C., Ferreira, I., Blaak, E. E., Feskens, E. J. M., Jansen, E. H. J. M., Schalkwijk, C., & Stehouwer, C. D. A. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02129.x · Cited by 114 · see citing works
Is the metabolic syndrome a risk factor for female sexual dysfunction in sexually active women?
Ponholzer, A., Temml, C., Rauchenwald, M., Martin Marszalek, A., & Stephan Madersbacher, A. (2007) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901605 · Cited by 96 · see citing works
The Key Role of Insulin Resistance in the Cardiometabolic Syndrome
Gill, H., Mugo, M. N., Whaley‐Connell, A. T., Stump, C. S., & Sowers, J. R. (2005) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200512000-00006 · Cited by 78 · see citing works
Metabolic Syndrome: Treatment of Hypertensive Patients
Israili, Z. H., Lyoussi, B., Hernández-Hernández, R., & Velasco, M. (2007) · American Journal of Therapeutics · doi:10.1097/01.pap.0000249936.05650.0c · Cited by 53 · see citing works
Sleep & the metabolic syndrome.
Lam, J., & Ip, M. (2010) · PubMed · Cited by 52 · see citing works
Renal manifestations of the metabolic syndrome
Tuttle, K. R. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh767 · Cited by 45 · see citing works
The hypolipidemic effects of gemfibrozil in type V hyperlipidemia. A double-blind, crossover study
Leaf, D. A. (1989) · JAMA · doi:10.1001/jama.262.22.3154 · Cited by 44 · see citing works
The Hypolipidemic Effects of Gemfibrozil in Type V Hyperlipidemia
LEAF, D. A. (1989) · JAMA · doi:10.1001/jama.1989.03430220077034 · Cited by 40 · see citing works
Aetiology and consequences of the metabolic syndrome
Standl, E. (2005) · European Heart Journal Supplements · doi:10.1093/eurheartj/sui023 · Cited by 38 · see citing works
Metabolic Syndrome Pathophysiology and Clinical Presentation
Handelsman, Y. (2008) · Toxicologic Pathology · doi:10.1177/0192623308329288 · Cited by 36 · see citing works
Metabolic Aspects of Bariatric Surgery
Folli, F. B., Pontiroli, A. E., & Schwesinger, W. H. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2007.01.005 · Cited by 34 · see citing works
Ocular associations of metabolic syndrome
Jacob, J. J., Chopra, R., & Chander, A. (2012) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.94244 · Cited by 27 · see citing works
Intensified Screening and Treatment of the Metabolic Syndrome for Cardiovascular Risk Reduction
Wong, N. D. (2005) · Preventive Cardiology · doi:10.1111/j.1520-037x.2005.4073.x · Cited by 26 · see citing works
Prevention of Type 2 Diabetes With Troglitazone in the Diabetes Prevention Program
Kennedy, L. (2006) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70264-6 · Cited by 22 · see citing works
Olijhoek, J. K., van der Graaf, Y., & Banga, J. (2004) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2004.09.007 · Cited by 13 · see citing works
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7
Flagged first, then by citations
1 of the 49 references couldn’t be matched to a known paper.
Research works printed but not linked: 10
- [11]11. Palaniappan L, Carnethon MR, Wang Y et al. Predictors of the incident metabolic syndrome in adults: The Insulin Resistance Atherosclerosis Study. Diabetes Care 2004; 27(3):788-93.
- [12]12. Alberti KGMM, Eckel RH, Grundy SM et al. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; And international association for the study of obesity. Circulation 2009; 120(16):1640-5.
- [16]16. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation: European Group for the Study of Insulin Resistance (EGIR). Diabetic Medicine 1999; 16(5):442-3.
- [21]21. Wallace AM, McMahon AD, Packard CJ et al. On behalf of the WOSCOPS Executive Committee. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 2001; 104(25):3052-6.
- [32]32. Padhi T, Garima Metabolic syndrome and skin: psoriasis and beyond. Indian Journal of Dermatology 2013; 58(3):299-305.
- [43]43. Thompson PD, Buchner D, Piña IL et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: A statement from the council on clinical cardiology (subcommittee on exercise, rehabilitation, and prevention) and the council on nutrition, physical activity and metabolism (subcommittee on physical activity) Circulation 2003; 107(24):3109-16.
- [44]44. Grundy SM, Hansen B, Smith SC et al. American Heart Association; National Heart, Lung, and Blood Institute; American Diabetes Association. Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 2004; 109(4):551-6.
- [45]45. Wilson PWF, Grundy SM. The metabolic syndrome practical guide to origins and treatment: part I. Circulation 2003; 108(12):1422-4.
- [47]47. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. The Lancet 2005; 365(9468):1415-28.
- [50]50. Kashyap ML, McGovern ME, Berra K et al. Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia. The American Journal of Cardiology 2002; 89(6):672-8.
Cited by
Sorted by citations
He, Y., Chen, Z., Tang, Z., Qin, Y., & Wang, F. (2025) · BMC Public Health · doi:10.1186/s12889-025-23858-y · Cited by 5 · see citing works
- Authors
- Rahman, Q. A. A., Razzak, M. A., & Wahab, M. A.
- Affiliations
- Armed Forces Medical College (BD)
- Venue
- Journal of Armed Forces Medical College, Bangladesh
- Publisher
- Bangladesh Journals Online (JOL)
- Published
- 2020-03-10
- Volume
- 14
- Issue
- 2
- Pages
- 203-208
- ISSN
- 1992-5743 (ISSN-L)
- OpenAlex
- W3046834602
- Cited by
- 1
- References
- 49
- Citations by year
- 2025: 1
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Journal of Armed Forces Medical College Bangladesh (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- metabolic syndrome, hypertension, abdominal obesity, insulin resistance, dyslipidemia, cardiovascular disease, diabetes mellitus, inflammation, obesity, diagnostic criteria, pathogenesis, disease management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review